Delivery Order SPE2DB22D1202-SPE2DB24FUPQ3
- Not listed
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,679.74, is a delivery order with a firm fixed price. It has a performance period ending on May 16, 2023. The contract was awarded on May 15, 2023, and there is no set-aside designation mentioned....
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,547.27, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a completion date of June 4, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The contract, valued at $20,084.57, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The $3,019.74 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical....
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,581.47 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Velphoro 500 mg chewable tablets. The firm-fixed-price delivery order, valued at $1,261.19, has a completion date of September 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,429.90 and an ultimate completion date of January 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The award is associated with a larger Indefinite Delivery...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, which is the Corporate Office division of the larger Amerisourcebergen Corporation. The contract has a firm fixed price of $4,302.99 and a completion date of April 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $22,231.95. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 8, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,784.58 and an ultimate completion date of December 8, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUPQ3Delivery Order
This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,830.86 and an ultimate completion date of February 6, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 2/5/24 |